Insider Trading Activity - Atlas Venture Associates XI L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Atlas Venture Associates XI L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-02-26 Sale	2024-02-28 7:13 pm	Dyne Therapeutics Inc.	DYN	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner	807,838	$24.3	$19,626,903	6,562,578 (Indirect Direct)	View
2024-02-21 Sale	2024-02-23 6:58 pm	Dyne Therapeutics Inc.	DYN	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner	500,789	$22.64	$11,339,780	7,273,405 (Indirect Direct)	View
2024-02-15 Sale	2024-02-20 6:35 pm	Dyne Therapeutics Inc.	DYN	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner	510,152	$23.26	$11,867,292	6,815,965 (Direct)	View
2024-02-08 Sale	2024-02-09 4:33 pm	Xilio Therapeutics Inc.	XLO	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	1,000	$0.64	$640	2,754,109 (Indirect Direct)	View
2024-01-11 Sale	2024-01-16 6:16 pm	Xilio Therapeutics Inc.	XLO	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	4,235	$0.85017	$3,600	2,755,109 (Indirect Direct)	View
2022-12-12 Purchase	2022-12-14 4:55 pm	Dyne Therapeutics Inc.	DYN	Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner	934,581	$10.7	$10,000,017	9,869,483 (Indirect Direct)	View
2022-09-19 Purchase	2022-09-19 4:51 pm	Third Harmonic Bio Inc.	THRD	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	300,000	$17	$5,100,000	594,096 (Direct)	View
2022-06-17 Purchase	2022-06-22 5:09 pm	Day One Biopharmaceuticals Inc.	DAWN	Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	766,667	$15	$11,500,005	8,984,019 (Indirect Direct)	View
2021-03-30 Purchase	2021-12-14 8:27 pm	Ikena Oncology Inc.	IKNA	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	125,000	$16	$2,000,000	2,116,569 (Indirect Direct)	View
2021-12-10 Sale	2021-12-14 8:27 pm	Ikena Oncology Inc.	IKNA	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	26,278	$14.67	$385,572	2,116,569 (Indirect Direct)	View
2021-06-01 Purchase	2021-06-02 6:40 pm	Day One Biopharmaceuticals Inc.	DAWN	Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner	500,000	$16	$8,000,000	991,396 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
Ownership	2023-11-07 9:05 pm	N/A N/A	Korro Bio Inc.	KRRO	Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner	0	$0	1,119,292 (Direct)	View
2022-09-19 Conversion	2022-09-19 4:51 pm	N/A N/A	Third Harmonic Bio Inc.	THRD	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	13,538,844	$0	594,096 (Direct)	View
Ownership	2022-09-14 6:03 pm	N/A N/A	Third Harmonic Bio Inc.	THRD	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	0	$0	10,607,860 (Direct)	View
Ownership	2021-10-21 8:48 pm	N/A N/A	Xilio Therapeutics Inc.	XLO	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	0	$0	2,571,844 (Indirect)	View
2021-06-01 Conversion	2021-06-02 6:40 pm	N/A N/A	Day One Biopharmaceuticals Inc.	DAWN	Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner	8,502,776	$0	991,396 (Indirect)	View
2021-03-30 Conversion	2021-04-01 6:16 pm	N/A N/A	Ikena Oncology Inc.	IKNA	Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	38,734,459	$0	749,634 (Indirect)	View
Ownership	2021-03-25 8:09 pm	N/A N/A	Ikena Oncology Inc.	IKNA	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	0	$0	4,919,456 (Indirect)	View
2020-09-21 Conversion	2020-09-23 6:56 pm	N/A N/A	Dyne Therapeutics Inc.	DYN	Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	32,974,690	$0	1,608,785 (Indirect)	View
Ownership	2020-09-16 8:39 pm	N/A N/A	Dyne Therapeutics Inc.	DYN	Atlas Venture Fund XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates XI L.P. Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	0	$0	9,748,915 (Indirect)	View

Insider Trading & Ownership - Atlas Venture Associates XI L.P.